{"id":"NCT00093015","sponsor":"Amgen","briefTitle":"Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)","officialTitle":"Trial to Reduce Cardiovascular Events With Aranesp® Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-08-01","primaryCompletion":"2009-03-01","completion":"2009-07-01","firstPosted":"2004-09-29","resultsPosted":"2010-09-02","lastUpdate":"2022-11-08"},"enrollment":4038,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Kidney Disease","Diabetes Mellitus","Anemia"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"darbepoetin alfa","otherNames":[]}],"arms":[{"label":"Active","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the impact of treatment of anemia with darbepoetin alfa to a hemoglobin target of 13 g/dL on (1) all-cause mortality and nonfatal cardiovascular events, and (2) progression to end-stage renal disease or death, in subjects with chronic kidney disease and type 2 diabetes mellitus.\n\nAcademic PI/Executive Committee Chairman: Marc Pfeffer, MD, PhD","primaryOutcome":{"measure":"Time to All-cause Mortality or Cardiovascular (CV) Events Including Hospitalization Due to Acute Myocardial Ischemia, Congestive Heart Failure (CHF), Myocardial Infarction (MI), and Cerebrovascular Accident (CVA)","timeFrame":"Until a primary cardiovascular event (death, myocardial ischemia, congestive heart failure, myocardial infarction or cerebrovascular accident) occurred or 28 March 2009, whichever occurred first","effectByArm":[{"arm":"Placebo","deltaMin":602,"sd":null},{"arm":"Darbepoetin Alfa","deltaMin":632,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.41"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21212421","21982669","15864229","19880844","20843249","37651553","36791280","26299230","25452859","22104547","19501439","17329707"],"seeAlso":["http://download.veritasmedicine.com/REGFILES/amgen/Amgen_results_disclaimer.pdf","http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":1219,"n":2019},"commonTop":["Oedema peripheral","Fatigue","Hypertension","Pain in extremity","Dyspnoea"]}}